InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Edris Badreddin, Chief Operating Officer. Officer active across 2 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 8 reports have been logged. Total volume traded: €4.6m. The latest transaction was disclosed on 7 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€91,9041,852 shares@ €49.62433.6% of flow
Common Stock
SEC:0001104659-22-004462·
€91,9041,852 shares@ €49.62431.8% of flow
Common Stock
SEC:0001104659-22-004462:0·
€125,5992,531 shares@ €49.62435.0% of flow
Common Stock
SEC:0001104659-22-003142·
€125,5992,531 shares@ €49.62432.5% of flow
Common Stock
SEC:0001104659-22-003142:0·
26,124 shares
Common Stock
SEC:0001104659-22-002752·
26,124 shares
Common Stock
SEC:0001104659-22-002752:0·
€2m32,000 shares@ €72.045291.4% of flow
Common Stock
SEC:0001104659-21-088377·
€2m32,000 shares@ €72.045245.7% of flow
Common Stock
SEC:0001104659-21-088377:0·
8 of 8 declarations
About Edris Badreddin
Edris Badreddin serves as Chief Operating Officer at SpringWorks Therapeutics, Inc. In this role, he oversees the daily operations of the company and ensures that processes are optimized to achieve strategic objectives. His expertise in operational management enables him to effectively lead teams and ensure customer satisfaction. He plays a key role in the continuous improvement of SpringWorks' performance.
